HTLS 2022: ‘Fighting future pandemics needs sustained attention’

Dr Vas Narasimhan, the chief executive officer of pharma firm Novartis, shares insights on his learnings from the Covid-19 pandemic, the technologies of medicines of tomorrow, and the need to tackle health emergencies